• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA OKs World's First Single-Use Duodenoscope

    Dr. Stephen Hahn Confirmed as New FDA Leader

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

    MedStar Health and Cleveland Clinic Innovations Awarded Grant

    3M to Sell Drug Delivery Business for $650M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Halkey-Roberts Corporation

    MicroLumen Inc.

    Glenbrook Technologies Inc.

    K-Tube Technologies

    Zeus
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EU's MDR: Irresistible Force Meets Immovable Object

    Ladies First: An Examination of the Women's Health Device Industry

    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Zeus

    S-Y-M Products Company

    NN Life Sciences/Paragon Medical

    Halkey-Roberts Corporation

    Command Medical Products Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Developing Market Access Strategies

    Developing Market Access Strategies
    Related CONTENT
    • My Holiday Wish List (for Industry)
    • Mike on Medtech: Holiday Wish List, Part 1
    • What Is This Thing Called 'Cybersecurity' Anyway?
    • Sounding Board: 2018 Reflections and Looking Ahead
    • FDA's New Actions Concerning the Digital Health Pre-Cert Pilot Program
    Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors05.01.19
    Clearly, innovation is one of the keys to success for medtech OEMs and their suppliers. But it’s not the only key—market access is equally as important to long-term growth, as it helps drive immediate sales and generate a return on investment for entrepreneurs. Consequently, companies must embrace and incorporate market access strategies early in the product development cycle to thrive in today’s value-based, payer-dominant healthcare environment. 

    A successful market access strategy requires an understanding of patient needs, a focus on payer perspectives, and pragmatic, viable solutions. It must also be flexible enough to evolve with market dynamics and varying changes in device pricing, reimbursement, and regulations. This column provides an overview of key markets and the necessary ingredients involved in developing solid market access strategies for workable Class II products (assuming these products have the proper sales and marketing support, of course).

    Accordingly, there are two key components to successful market access strategies: regulatory clearance, which authorizes device sales in a specific country or region; and product reimbursement (note: for the purposes of this discussion, reimbursement may also include clinical economic evidence of cost savings for a given solution).

    Targeting the U.S. Market
    U.S. regulatory clearance is administered by the U.S. Food and Drug Administration (FDA). While it has traditionally been slow and unresponsive, the FDA has morphed into a dynamic organization that is currently updating its authorization guidelines for new technologies and clarifying its positions on existing product classifications. Two areas of innovation requiring specific guidance from the FDA in recent years are wearables and software. The highly flexible nature of product development in these emerging fields has triggered a plethora of questions from manufacturers about device classification and regulation. As a result, the FDA has spent considerable time stating its position on these topics and been increasingly accessible to meet with companies (in advance of a submission) to discuss potential product classification and the clinical evidence necessary for FDA clearance.

    Reimbursement has become just as critical as regulatory clearance in accessing the U.S. market. In the past, companies receiving FDA clearance used their commercialization prowess to gain market share in the United States. That approach doesn’t work anymore, though. Technologies that fail to propagate cost savings or reimbursement from insurers will die a quick death in the market.

    Thus, to successfully launch new products/technologies in the United States, medtech firms must develop a reimbursement strategy driven by clinical economic evidence. This evidence must be ready at product launch and made clear to potential customers as a well-defined reimbursement plan will help induce adoption of the new innovation.

    In developing a reimbursement strategy, companies should take advantage of the FDA’s accessibility and engage in “pre-submission” discussions with the agency. Avoiding the FDA and then submitting a product for clearance is an unnecessary gamble and likely will result in increased time to market, added expenses, and a strained relationship with regulators.

    European Variety
    Launching a product in the European Union (EU) often makes companies nervous because the EU is actually 28 separate, distinct countries (and cultures). Hence, companies considering introducing their products in Europe should first identify the countries they want to enter and then tailor market access strategies specifically for those areas.

    Product launches in Europe require the same basic ingredients as their American counterparts: regulatory clearance (through the CE mark and Medical Device Regulation [MDR] processes) and a solid reimbursement plan.

    For years, it was relatively easy to launch a product in Europe—companies simply gained a CE mark, registered in the desired countries, and began marketing their wares. But the new MDR, which has a compliance deadline of May 2020, has made the EU’s authorization system considerably more strenuous and complex than the American method (quite frankly, it’s easier now to start a clinical trial in the United States than in Europe). Adding to that complexity is the fact the MDR and CE mark processes require the use of Notified Bodies for product certification, and these entities are now racing against the clock to conduct audits and accredit both manufacturers and medical devices before the 2020 deadline.

    Medtech firms can ensure such complexity doesn’t impact their market access strategies by identifying the proper Notified Body for regulatory clearance. In addition, companies must match their product innovation process to their regulatory plan in order to avoid delays or problems in attaining regulatory clearance for their devices.

    Reimbursement is equally as important in most of Europe as it is in America. But with many countries operating their own healthcare systems, it has become necessary for companies to demonstrate the economic cost benefits associated with their product—a task that can sometimes be frustrating and time consuming (particularly with all the different countries at play). Such hassles, however, can be minimized by a prioritization of desired countries for market entry, and a clear demonstration of clinical and economic benefits that will convince customers in those state-run health systems to use the product.

    Open Collaboration in Japan
    Fortunately, Japan has been modernizing its regulatory approach in recent years to encourage market introduction of new technology. While it is still fairly challenging, the Japan Pharmaceuticals and Medical Devices Agency (PMDA) is nonetheless now more open to a collaborative process to help guide companies through the approval process. Since Japan is driven by a national healthcare system, organizations targeting this market must make PMDA clearance a priority and realize that approval—as in other areas of the world—hinges on proof of a product’s cost benefit. Companies that cannot provide this proof likely will be denied access to this market.

    To significantly improve their chances of market penetration, medtech firms should meet with the PMDA early for guidance on the clinical and economic evidence that is acceptable and necessary for regulatory approval.

    Constant Changes Complicating Chinese Market Access
    China recently has become one of the most difficult markets to access globally. But it wasn’t always that way—historically, it was relatively easy to gain product approval; the difficulty came in navigating the country’s complex distribution channel structure. Now, that dynamic is reversed. Although the channel structure remains a bit complex, numerous Western companies have successfully mastered channel access (either directly or with a local partner) to indicate it’s possible to win there. Nevertheless, attaining product approval through the new NMPA (National Medical Products Administration) has become increasingly more difficult, even for Chinese companies. One of the main factors complicating the approval process is the ever-evolving nature of China’s central regulatory body itself keeps changing (i.e., from State Food and Drug Administration to China Food and Drug Administration to NMPA). Correspondingly, each name change has generated more regulatory complexity and triggered rule changes. It should not be surprising then, that the NMPA is in the process of updating its rules regarding approval for various product classification.

    Indeed, market access in China is difficult but not impossible. Companies hoping to conquer this market should ensure their regulatory teams include a specialist who understands the NMPA’s changing nature and the rules associated with product approvals. With any luck, those rules won’t change before the product launches.

    Reimbursement, like regulatory clearance, is also very complex in China because—for the most part— it is not handled at a national level. While various products receive classifications at a country level, the reimbursements are often decided at a regional level. This scenario can make it lucrative to launch a product in one region of China and highly unprofitable to enter another region of the country.

    Companies looking to break into the Chinese market should ensure their market development teams assess the various reimbursement rates for specific products within each region of the Middle Kingdom and then begin prioritizing the areas best suited for an initial product launch.

    There obviously are more global markets than those outlined in this column. But companies that successfully sell products in these countries will be well on their way to global market leadership for their technological solutions. And it all begins with a sound market access strategy. 


    Florence Joffroy-Black, CM&AA, is a longtime marketing and M&A expert with significant experience in the medical technology industry, including working for multi-national corporations based in the United States, Germany, and Israel. She can be reached at florencejblack@medworldadvisors.com.

    Dave Sheppard, CM&AA, is a former medical technology Fortune 500 executive and is now a managing director at MedWorld Advisors. He can be reached at davesheppard@medworldadvisors.com. 
    Related Searches
    • regulations
    • regulatory
    • technology
    • patient
    Suggested For You
    MedWorld Advisors MedWorld Advisors
    FDA Approves Device to Help Increase Access to More Lungs for Transplant FDA Approves Device to Help Increase Access to More Lungs for Transplant
    A New, Tailored Review Framework for Artificial Intelligence-Based Devices A New, Tailored Review Framework for Artificial Intelligence-Based Devices
    FDA to Modernize Mammography Services and Improve Their Quality FDA to Modernize Mammography Services and Improve Their Quality
    FDA Warns J&J and Sientra for Breast Implant Compliance Failure FDA Warns J&J and Sientra for Breast Implant Compliance Failure
    FDA to Closely Examine Surgical Stapler Risks FDA to Closely Examine Surgical Stapler Risks
    FDA Commissioner Scott Gottlieb to Step Down FDA Commissioner Scott Gottlieb to Step Down
    ICU Medical Recalls ChemoLock Vial Spike (20mm) Due to Risk of Detached Plastic Particles ICU Medical Recalls ChemoLock Vial Spike (20mm) Due to Risk of Detached Plastic Particles
    FDA Orders Doctor to Cease Marketing Unapproved Breast Augmentation Device FDA Orders Doctor to Cease Marketing Unapproved Breast Augmentation Device
    Small Steps Small Steps
    Research & Development Feature Trailer 2019 Research & Development Feature Trailer 2019
    Latest Steps to Strengthen FDA’s 510(k) Program for Premarket Review Latest Steps to Strengthen FDA’s 510(k) Program for Premarket Review
    Strategies for Maximizing Your Supply Chain Strategies for Maximizing Your Supply Chain
    CES 2019: 7 More Health Tech Highlights CES 2019: 7 More Health Tech Highlights
    CES 2019: 10 Health Tech Highlights CES 2019: 10 Health Tech Highlights

    Related Columns

    • Diagnostics
      From Genome Sequencing to the World’s First Portable MRI

      From Genome Sequencing to the World’s First Portable MRI

      Dr. Jonathan Rothberg has risen about as high as a scientist can, save for the Nobel Prize.
      Sam Brusco, Associate Editor 11.04.19

    • Digital Health
      An Update on Digital Health

      An Update on Digital Health

      Sure, most are startups—but not all. There were some brilliant ideas presented at The MedTech Conference (AdvaMed’s annual meeting) on Sept. 23-25 in Boston and the Connected Health Conference, also in Boston, put on by Partners Health…
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.19

    • ‘If You’re Reading This, You Need to Be at This Meeting’

      ‘If You’re Reading This, You Need to Be at This Meeting’

      The AAOS/FDA/Industry Townhall is taking place March 24, 2020, at the AAOS annual meeting in Orlando.
      Dawn A. Lissy, President & Founder, Empirical 11.04.19


    • Five Steps for Succeeding Globally in Medtech

      Five Steps for Succeeding Globally in Medtech

      World views can differ considerably, so it is important to understand, appreciate, and respect cultural realities and differences.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.19

    • Software & IT
      Unlocking Market Doors with Real-World Evidence

      Unlocking Market Doors with Real-World Evidence

      Real-world evidence is becoming increasingly important for manufacturers to demonstrate value beyond efficacy and safety standards.
      Seth Goldenberg, Ph.D., Vice President, Vault Medical Device & Diagnostics, Veeva Systems 11.04.19

    • Contract Manufacturing
      Sales Tips for Contract Manufacturers of Finished Devices

      Sales Tips for Contract Manufacturers of Finished Devices

      Evolving trends in the supply chain may require companies to consider a strategy of selling devices of their own design.
      Tony Freeman, President, A.S. Freeman Advisors LLC 11.04.19


    • Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      The final quarter of 2019 has begun, which means Congress and the Trump Administration are hard at work finalizing healthcare initiatives before year's end.
      Jeffrey J. Kimbell, David C. Rudloff and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc. 11.04.19

    • R&D & Design
      Perfecting Drug Delivery Device Design

      Perfecting Drug Delivery Device Design

      Unlike medical products that just need to work, drug delivery devices must also consider intuitiveness, usability, and how it makes the user feel when operated.
      Bryce G. Rutter, Ph.D., Founder & CEO, Metaphase Design Group Inc. 11.04.19

    • Diagnostics
      Elizabeth Holmes: The Making of a Pop Culture Icon

      Elizabeth Holmes: The Making of a Pop Culture Icon

      Despite keeping a relatively low profile this year (not by choice), Elizabeth Holmes’ celebrity status has continued to grow.
      Michael Barbella, Managing Editor 10.08.19


    • A Look at Physician/Surgeon Salary and Employment Statistics

      A Look at Physician/Surgeon Salary and Employment Statistics

      No more call for physicians? Not really, but schedule predictability is in for physicians.
      Maria Shepherd, President and Founder, Medi-Vantage 10.08.19

    • Bridging Generation Gaps to Build Better Teams and Business

      Bridging Generation Gaps to Build Better Teams and Business

      I’ve learned the hard way that building teams of motivated, productive employees is equal parts science and art.
      Dawn A. Lissy, President & Founder, Empirical 10.08.19

    • Testing
      Managing Risks for Medical Devices:  A Guide to Understanding ISO 14971

      Managing Risks for Medical Devices: A Guide to Understanding ISO 14971

      The intent of ISO 14971 is to provide a general “bird’s-eye view” approach to designing and implementing a risk management plan for medical devices.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Labs 10.08.19

    • Testing
      Preparing for MDR: Test In-House or Outsource?

      Preparing for MDR: Test In-House or Outsource?

      As the EU MDR deadline draws near, manufacturers are under pressure to bring products into compliance and get submissions in front of regulators ASAP.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi Medical Device Testing 10.08.19

    • Think Chinese Tariffs Are the Only Industry Job Killers? Think Again

      Think Chinese Tariffs Are the Only Industry Job Killers? Think Again

      One of the latest concerns—arising from an old issue—is the medical device tax, which could return next year without legislative intervention before then.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 10.08.19

    • Contract Manufacturing | Software & IT
      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Industry 4.0 represents the dawn of the digital transformation that began with the third revolution, connecting the physical and natural worlds.
      Scott Reedy, Senior Director of Marketing, Arena Solutions 10.08.19


    Breaking News
    • FDA OKs World's First Single-Use Duodenoscope
    • Dr. Stephen Hahn Confirmed as New FDA Leader
    • FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    • MedStar Health and Cleveland Clinic Innovations Awarded Grant
    • 3M to Sell Drug Delivery Business for $650M
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.